Medium-Term Management Plan VISION2025 and Consolidated Net Sales of ¥50 Billion
First written in FY2021. 11 of 14 entries say "Restated". Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1RestatedAnnual report
「Against this market backdrop, the Group addressed key activities based on the medium-term management plan “Growth Next 2027” to realize its PURPOSE of “Creating a smiling everyday life through the ‘new’ in beauty and health.”」
The group continued its priority activities under Growth Next 2027 during the current interim consolidated accounting period. - FY2025RestatedAnnual report
「The plan covers fiscal years 2025 through 2027 and is positioned as a period for establishing the foundation for global expansion toward realizing the purpose. The group aims to achieve the medium-term management targets for the fiscal year ending September 2027 of sales of ¥52 billion, operating profit of ¥6 billion and an operating margin of 11.5%. It also targets ROE of at least 15% and a consolidated dividend payout ratio of at least 35%.」
The annual report reconfirms Growth Next 2027’s covered fiscal years and targets of sales of ¥52 billion, operating profit of ¥6 billion, an operating margin of 11.5%, ROE of at least 15% and a consolidated dividend payout ratio of at least 35%. - FY2025-H1RestatedAnnual report
「Against this market backdrop, the Group addressed key issues based on the medium-term management plan “Growth Next 2027” to realize its PURPOSE of “Creating a smiling everyday life through the ‘new’ in beauty and health.”」
The group continued to address its priority initiatives under the medium-term management plan Growth Next 2027, which followed VISION2025. - FY2024ReframedAnnual report
「In November 2024, a new medium-term management plan, Growth Next 2027, was formulated. Covering fiscal years 2025 through 2027, the plan is positioned as a period for establishing the foundation for global expansion toward realizing the purpose of “creating a smile-filled everyday life through the new in beauty and health.” The group aims to achieve the medium-term management targets for the fiscal year ending September 2027 of sales of ¥52 billion, operating profit of ¥6 billion and an operating margin of 11.5%. It also targets ROE of at least 15% and a consolidated dividend payout ratio of at least 35%.」
The medium-term management plan was revised from VISION2025 to Growth Next 2027, covering fiscal years 2025 through 2027. Targets were set at sales of ¥52 billion, operating profit of ¥6 billion, an operating margin of 11.5%, ROE of at least 15% and a consolidated dividend payout ratio of at least 35%. - FY2024-Q2RestatedAnnual report
「Against this market backdrop, the Group addressed key issues based on the medium-term management plan “VISION2025” to realize its PURPOSE of “Creating a smiling everyday life through the ‘new’ in beauty and health.”」
The group continued to address its priority initiatives under VISION2025. - FY2024-Q1RestatedAnnual report
「Against this market backdrop, the Group addressed key issues based on the medium-term management plan “VISION2025” to realize its PURPOSE of “Creating a smiling everyday life through the ‘new’ in beauty and health.”」
The group continued to address its priority initiatives under VISION2025. - FY2023AdvancedAnnual report
「We recognize that, to grow Perfect One into a global brand, it will be necessary to shift from the previous Asia and ASEAN strategy centered on China and Taiwan to a global strategy, taking into account growth opportunities and country risks in each country and region. We recognize that expansion into the US market, the world’s largest cosmetics market, is a particularly important issue, and established a subsidiary in the United States in July 2023. While continuing a certain level of investment in the Asia and ASEAN regions, we will begin expanding into the US market from the fiscal year ending September 2024.」
The policy of making VISION2025 a global brand was shifted from an Asia- and ASEAN-centered strategy to a global strategy, with specific steps outlined for beginning US expansion in the fiscal year ending September 2024. - FY2023-Q3RestatedAnnual report
「Against this market backdrop, the group addressed its priority initiatives under the medium-term management plan VISION2025.」
The group continued to address its priority initiatives under the medium-term management plan VISION2025. - FY2023-Q2RestatedAnnual report
「Against this market backdrop, the group addressed its priority initiatives under the medium-term management plan VISION2025.」
The group continued to address its priority initiatives under the medium-term management plan VISION2025. - FY2023-Q1RestatedAnnual report
「Against this market backdrop, the group addressed its priority initiatives under the medium-term management plan VISION2025.」
The group continued to address its priority initiatives under the medium-term management plan VISION2025. - FY2022-Q3RestatedAnnual report
「Against this market backdrop, the group addressed its priority initiatives under the four-year medium-term management plan VISION2025, whose first year is the current consolidated fiscal year.」
The group continued to address its priority initiatives based on the four-year medium-term management plan VISION2025. - FY2022-Q2RestatedAnnual report
「Against this market backdrop, the group addressed its priority initiatives under the four-year medium-term management plan VISION2025, whose first year is the current consolidated fiscal year.」
The group continued to advance its priority initiatives under the four-year medium-term management plan VISION2025. - FY2022-Q1RestatedAnnual report
「Against this market backdrop, the group worked to advance its priority initiatives under the four-year medium-term management plan VISION2025, whose first year is the current consolidated fiscal year.」
The group continued to implement the four-year medium-term management plan VISION2025 and advance its priority initiatives. - FY2021First statedAnnual report
「The medium-term management plan VISION2025, with the fiscal year ending September 2022 as its first year, was formulated. To achieve the management target of consolidated sales of ¥50 billion, VISION2025 promotes priority initiatives under the themes of “making Perfect One a global brand” and “making the healthcare business the next core business,” with the aim of achieving sustainable growth.」
VISION2025, with the fiscal year ending September 2022 as its first year, was formulated, with targets of consolidated sales of ¥50 billion, establishing Perfect One as a global brand and making healthcare the next core business.